 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
. e' x Q4 q* H% y9 b- j/ u 5 G# R" `; C; O0 R; f' e
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
& G7 K$ O7 L" W/ u/ p9 \
; b6 P/ ]4 T ~BY THE EDMONTON JOURNAL FEBRUARY 16, 2007
- r0 ~, ~$ X- R8 I" U
+ m4 g. F/ U- U# N, q. U 2 I$ {! x, P. {% i! G2 L: I, d
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
. I' \/ q4 B- A& h6 D0 _9 n5 q* l5 }8 E' N/ d# g; Y9 T
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
5 r) V0 J- z' M2 l& f# L) E
9 [! h8 t( x" @. p+ o( ^) V# K9 xThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
& s/ x V0 [- J+ v' }( ]! ~6 s9 e8 s! [1 I; Z. `
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.# G4 o9 x. o. X3 \" z B) ?
: a3 W8 k9 F4 {" oIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
" D9 s6 p+ T$ a' ]' q1 {/ \% t: p. Z
"As a scientist, it's one of the highlights of my CAREER," Shan said.: [# ?! g1 t: V; S* k- o
- U0 F) s, z" F3 ~"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
8 N0 _9 e! T# N' \ O
- h5 C. `' H* q& NIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.5 R2 k. y$ f- R: }/ T5 c
' }4 ?% N7 o' `3 D6 s+ VGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
6 A d* C0 G% w3 U. X e$ w7 g$ N7 d0 c6 G
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.* ^4 O1 L' b7 ~# C( z
; v' x7 I- q) ?( S" \
; j, N: N3 i! v2 x+ x& S
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
: x+ G8 S G& x3 ~
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
